Search Results for "Brian Groves Pfizer Bio"

02:15 EST 20th December 2014 | BioPortfolio

Original Source: Advil® Launches Advil® Relief in Action Campaign Celebrating Active Volunteers Who Don’t Let Pain Hold Them Back

Pfizer Consumer Healthcare (NYSE: PFE), makers of Advil®, is kicking off its Advil® Relief in Action campaign today that honors volunteers who don’t let pain get in the way of providing relief to others in need. Advil® Relief in Action celebrates the efforts of these tireless everyday heroes, as well as supports and contributes to the efforts of Habitat for Humanity and Wounded Warrior Project® (WWP), whose volunteers exemplify Relief in Action and work...

Matching Channels


Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have ...

CTLA4 Mab rDNA Pfizer

Insulin rDNA inhaled Pfizer

Lymphocyte Immune Globulin Pfizer

Somatropin Hgh rDNA Pfizer

What is GENOTROPIN? GENOTROPIN (somatropin [rDNA origin] for injection) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference i...

Matching News

Pfizer leaves investors guessing on intentions for Astra

Pfizer Inc , which in May abandoned its $118 billion bid to buy AstraZeneca Plc , on Tuesday left investors guessing whether it would renew its pursuit of its British rival, but said it was considerin...

Pfizer Has It All Wrong, Should Look Into New Viable Acquisitions

By Long Term Bio:Pfizer (PFE) had recently announced that it was unable to reach a deal to merge with AstraZeneca (AZN). The final bid Pfizer gave was $116 billion dollars, and the company stated that...

Is Pfizer’s next acquisition target, Activas?

Bloomberg reports, Pfizer is looking at Actavis, the generics maker with a new home address in Ireland, among other targets. Pfizer may not get a great shot at buying AstraZeneca this fall–but...

Pfizer to Acquire InnoPharma

Pfizer and InnoPharma, a privately held pharmaceutical development company, today announced that they have entered into an agreement under which Pfizer will acquire InnoPharma.Under the terms of the a...

InnoPharma has entered into m&a with Pfizer

Pfizer and InnoPharma have entered into an m&a agreement under which Pfizer will acquire InnoPharma. Pfizer will acquire InnoPharma for an upfront cash payment of $225 million, with up to $135 mil...

Pfizer: Pfine With Or Without AstraZeneca

By DAG1996: Company Overview Founded by cousins Charles Pfizer and Charles Erhart in 1849, Pfizer (PFE) is a Fortune 500 company and the top pharmaceutical firm in the world by sales.Much of Pfizer'...

AstraZeneca shores up defences against Pfizer

AstraZeneca has been making a series of big deals over the past three months as it looks to close the door once and for all on any Pfizer merger.  AZ rebuffed Pfizer’s $118 billion offer for th...

BRIEF-Pfizer reaches $35 mln settlement over marketing of Rapamune

Aug 6 (Reuters) - Pfizer Inc : * Ny ag schneiderman says Pfizer Inc has reached $35 million settlement

Matching PubMed Articles

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement